SCHEMBL5226437

SCHEMBL5226437

COc1ccc(S(=O)(=O)N[C@H](CO)C(=O)NO)cc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 7/20 0.58
MMP1 P03956 5/20 0.58
MMP2 P08253 5/20 0.58
MMP8 P22894 3/20 0.58
MMP9 P14780 2/20 0.58
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
BMP1 P13497 8/20 0.55
MMP3 P08254 3/20 0.54
CA12 O43570 1/20 0.52
CA9 Q16790 1/20 0.52
CA14 Q9ULX7 1/20 0.52
MMP7 P09237 2/20 0.52
MMP12 P39900 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
MEP1B Q16820 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1565606 1.00 MMP13 (0.58) MMP13MMP1MMP2MMP8MMP9
SCHEMBL7416701 0.89 ALDH1A1 (0.58) MMP13MMP1MMP2MMP8MMP9
SCHEMBL7461414 0.88 MMP13 (0.56) MMP13MMP1MMP2MMP8MMP9
SCHEMBL7417246 0.86 MMP7 (0.65) MMP13MMP1MMP2MMP8MMP9
SCHEMBL5639380 0.86 MMP2 (0.57) MMP13MMP1MMP2MMP8MMP9
SCHEMBL4621504 0.86 MMP2 (0.66) MMP13MMP1MMP2MMP8MMP9
SCHEMBL4620929 0.86 MMP2 (0.66) MMP13MMP1MMP2MMP8MMP9
SCHEMBL4619626 0.86 MMP2 (0.66) MMP13MMP1MMP2MMP8MMP9
SCHEMBL8023829 0.84 BMP1 (0.59) MMP13MMP1MMP2MMP8MMP9
SCHEMBL8436170 0.83 MMP13 (0.51) MMP13MMP1MMP2MMP8MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1781601-A2 DERIVATIVES OF ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACID AS MATRIX METALLOPROTEINASES INHIBITORS Abiogen Pharma S.p.A. (IT) 2007-05-09 EP disclosed
WO-2006013193-A2 DERIVATIVES OF ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACID AS MATRIX METALLOPROTEINASES INHIBITORS ABIOGEN PHARMA S.P.A. (IT) 2006-02-09 WO disclosed